Pfizer Expects To Pay $772M To End Hormone Drug Suits
Pfizer Inc. said Thursday that it had resolved one-third of the suits filed over its hormone replacement therapy and that the drug company expected to spend at least $772 million to...To view the full article, register now.
Already a subscriber? Click here to view full article